(Q44749232)

5 December 2017

title

Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast (English)

1 reference

5 December 2017

H Yanagawa

1

1 reference

5 December 2017

A Sugita

2

1 reference

5 December 2017

M Azuma

3

1 reference

5 December 2017

H Ogawa

4

1 reference

5 December 2017

C Kitamuro

5

1 reference

5 December 2017

K Yoneda

6

1 reference

5 December 2017

K Shinkawa

7

1 reference

5 December 2017

K Tani

8

1 reference

5 December 2017

S Sone

9

1 reference

5 December 2017

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

182

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

51-58

1 reference

Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist

5 December 2017

cites work

1 reference

12 December 2020

Leukotriene modifiers: new drugs, old and new reactions

1 reference

12 December 2020

The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma

1 reference

12 December 2020

Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial

1 reference

12 December 2020

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

12 December 2020

Molecular and cellular mechanisms of allergic disease

1 reference

12 December 2020

Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

1 reference

12 December 2020

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

1 reference

12 December 2020

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

12 December 2020

Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study

1 reference

12 December 2020

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial

1 reference

12 December 2020

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

12 December 2020

A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group

1 reference

12 December 2020

Inhaled corticosteroids: impact on asthma morbidity and mortality

1 reference

12 December 2020

1 reference

12 December 2020

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

1 reference

12 December 2020

10.1007/S00408-003-1044-8

Identifiers

DOI

1 reference

5 December 2017

1 reference